Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Mar 08, 2021

SELL
$2.22 - $3.78 $152,181 - $259,119
-68,550 Closed
0 $0
Q3 2020

Dec 02, 2020

BUY
$2.39 - $13.08 $69,178 - $378,600
28,945 Added 73.08%
68,550 $172,000
Q2 2020

Sep 04, 2020

BUY
$6.67 - $13.58 $264,165 - $537,835
39,605 New
39,605 $538,000

Others Institutions Holding AKBA

About Akebia Therapeutics, Inc.


  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $438M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track Teachers Retirement System Of The State Of Kentucky Portfolio

Follow Teachers Retirement System Of The State Of Kentucky and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teachers Retirement System Of The State Of Kentucky, based on Form 13F filings with the SEC.

News

Stay updated on Teachers Retirement System Of The State Of Kentucky with notifications on news.